Clinician's assessment of improvement of hirsutism Ferriman‐Gallwey score Scale from: 0 to 36 · women with hirsutism
1 finding from 1 review
Change in serum androgen levels · women with hirsutism
1 finding from 1 review
Change in BMI ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement of other clinical signs of hyperandrogenism ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anaemia at end of therapy (total), as defined by trial authors · menstruating women (non‐pregnant women of reproductive age)
The intervention probably leads to lower anaemia at end of therapy (total), as defined by trial authors (moderate certainty).
1 finding from 1 review
Intervention not reported
Haemoglobin at end of therapy (total), g/L · menstruating women (non‐pregnant women of reproductive age)
The intervention leads to higher haemoglobin at end of therapy (total), g/L (high certainty).
1 finding from 1 review
Death (all causes) · people with CKD
Patient‐centred outcomes for oral showed no clear difference in death (all causes) compared with IV iron (low certainty).
1 finding from 1 review
Cardiovascular mortality · people with CKD
It is very uncertain whether patient‐centred outcomes for oral changes cardiovascular death compared with IV iron (very low certainty).
1 finding from 1 review
Type of adverse event: allergic reactions/hypotension · people with CKD
Patient‐centred outcomes for oral may leads to higher type of adverse event: allergic reactions/hypotension compared with IV iron (low certainty).
1 finding from 1 review
Gastrointestinal effects · people with CKD
Patient‐centred outcomes for oral may leads to lower type of adverse event: all gastrointestinal adverse effects compared with IV iron (low certainty).
1 finding from 1 review
Type of adverse event: infection · people with CKD
Patient‐centred outcomes for oral showed no clear difference in type of adverse event: infection compared with IV iron (low certainty).
1 finding from 1 review
Numbers of non‐dialysis patients needing to commence dialysis · people with CKD
Patient‐centred outcomes for oral showed no clear difference in numbers of non‐dialysis patients needing to commence dialysis compared with IV iron (low certainty).
1 finding from 1 review
Blood transfusion · people with CKD
Patient‐centred outcomes for oral showed no clear difference in number requiring transfusion compared with IV iron (low certainty).
1 finding from 1 review
Intervention not reported
Overall survival · people diagnosed with chemotherapy‐induced anemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Hematopoietic response · people diagnosed with chemotherapy‐induced anemia
The intervention leads to higher hematopoietic response (high certainty).
1 finding from 1 review
Intervention not reported
Red blood cell transfusion · people diagnosed with chemotherapy‐induced anemia
The intervention probably leads to lower red blood cell transfusion (moderate certainty).
1 finding from 1 review
Intervention not reported
Median time to hematopoietic response · people diagnosed with chemotherapy‐induced anemia
The intervention showed no clear difference in median time to hematopoietic response (low certainty).
1 finding from 1 review
Intervention not reported
Mean change in hemoglobin (better indicated by higher values) · people diagnosed with chemotherapy‐induced anemia
The intervention may leads to higher mean change in hemoglobin (better indicated by higher values) (low certainty).
1 finding from 1 review
Intervention not reported
Quality of life (better indicated by higher values) · people diagnosed with chemotherapy‐induced anemia
The intervention showed no clear difference in quality of life (better indicated by higher values) (high certainty).
1 finding from 1 review
Intervention not reported
Thromboembolic events · people diagnosed with chemotherapy‐induced anemia
The intervention showed no clear difference in thromboembolic events (moderate certainty).
1 finding from 1 review